Bipolar disorder associated with interferon-alpha treatment.
作者信息
Iancu I, Sverdlik A, Dannon P N, Lepkifker E
机构信息
Psychiatric Department B, Sheba Medical Center, Tel Hashomer, Israel.
出版信息
Postgrad Med J. 1997 Dec;73(866):834-5. doi: 10.1136/pgmj.73.866.834.
Abstract
摘要
相似文献
1
Bipolar disorder associated with interferon-alpha treatment.与α-干扰素治疗相关的双相情感障碍
Postgrad Med J. 1997 Dec;73(866):834-5. doi: 10.1136/pgmj.73.866.834.
2
Nephrotic syndrome associated with alpha interferon therapy in chronic myeloid leukemia.
Clin Nephrol. 1997 Jul;48(1):59-60.
3
Interferon-alpha therapy for chronic myelogenous leukemia during pregnancy.
Am J Hematol. 1998 Sep;59(1):101-2. doi: 10.1002/(sici)1096-8652(199809)59:1<101::aid-ajh23>3.0.co;2-d.
4
The adverse influence of pretransplant interferon-alpha (IFN-alpha) on transplant outcome after marrow transplantation for chronic phrase chronic myelogenous leukemia increases with the duration of IFN-alpha exposure.对于慢性期慢性粒细胞白血病患者，移植前使用α干扰素（IFN-α）对骨髓移植后移植结果的不良影响会随着IFN-α暴露时间的延长而增加。
Blood. 1999 Mar 1;93(5):1779-10.
5
Chronic myeloid leukemia. Introduction.
Am J Health Syst Pharm. 2007 Dec 15;64(24 Suppl 15):S2-3. doi: 10.2146/ajhp070485.
6
Renal thrombotic microangiopathy induced by interferon-alpha.α干扰素诱导的肾血栓性微血管病
Nephrol Dial Transplant. 2001 Apr;16(4):846-8. doi: 10.1093/ndt/16.4.846.
7
Thrombotic thrombocytopenic purpura complicating chronic myelogenous leukemia treated with interferon-alpha. A report of two successfully treated patients.α-干扰素治疗慢性粒细胞白血病并发血栓性血小板减少性紫癜。两例成功治疗病例报告。
Acta Haematol. 1998;100(4):204-6. doi: 10.1159/000040905.
8
Development of hyperthyroidism during long term interferon therapy in a patient with chronic myelogenous leukemia: case report.
Endocr J. 1997 Oct;44(5):715-7. doi: 10.1507/endocrj.44.715.
9
[Interferon-alpha therapy in chronic myelogenous leukemia].
Rinsho Ketsueki. 2000 Apr;41(4):275-9.
10
[Preliminary results of interferon alpha treatment for patients with chronic myelogenous leukemia].
Pol Tyg Lek. 1996 May;51(19-22):283-4.
引用本文的文献
1
Dual transcripts of - & different polymorphisms in chronic myeloid leukaemia patients.慢性髓性白血病患者中的 - 双转录本及不同多态性
Indian J Med Res. 2016 May;143(Supplement):S136-S141. doi: 10.4103/0971-5916.191816.
2
Interferon-alpha induced mania during the adjuvant treatment of malignant melanoma.α干扰素在恶性黑色素瘤辅助治疗期间诱发躁狂症。
Ir J Med Sci. 2007 Jul-Sep;176(2):137-9. doi: 10.1007/s11845-007-0016-z. Epub 2007 Mar 30.
本文引用的文献
1
Fluoxetine treatment of depression caused by interferon-alpha.
Am J Gastroenterol. 1993 May;88(5):760-1.
2
Treatment of renal cell carcinoma with escalating doses of alpha-interferon.使用递增剂量的α-干扰素治疗肾细胞癌。
Chemotherapy. 1993 Sep-Oct;39(5):361-6. doi: 10.1159/000239148.
3
Suicide associated with alfa-interferon therapy for chronic viral hepatitis.与α-干扰素治疗慢性病毒性肝炎相关的自杀行为。
J Hepatol. 1994 Aug;21(2):241-3. doi: 10.1016/s0168-8278(05)80402-7.
4
Interferon-alpha can be used successfully in patients with hepatitis C virus-positive chronic hepatitis who have a psychiatric illness.
Eur J Gastroenterol Hepatol. 1995 Feb;7(2):165-8.
5
Chronic hepatitis C. Advances in diagnostic testing and therapy.慢性丙型肝炎。诊断检测与治疗的进展。
Arch Intern Med. 1994 Feb 28;154(4):387-92. doi: 10.1001/archinte.154.4.387.
6
Neuropsychiatric manifestations of human leukocyte interferon therapy in patients with cancer.癌症患者接受人白细胞干扰素治疗的神经精神表现。
JAMA. 1984 Aug 17;252(7):938-41.
7
Safety and tolerance of recombinant interferon alfa-2a (Roferon-A) in cancer patients.重组干扰素α-2a（罗扰素）在癌症患者中的安全性和耐受性。
Cancer. 1986 Apr 15;57(8 Suppl):1709-15. doi: 10.1002/1097-0142(19860415)57:8+<1709::aid-cncr2820571315>3.0.co;2-f.
8
Clinical studies of recombinant interferon alfa-2a (Roferon-A) in cancer patients.重组干扰素α-2a（罗扰素-A）在癌症患者中的临床研究。
Cancer. 1986 Apr 15;57(8 Suppl):1705-8. doi: 10.1002/1097-0142(19860415)57:8+<1705::aid-cncr2820571314>3.0.co;2-u.
9
Psychiatric complications of long-term interferon alfa therapy.长期干扰素α治疗的精神科并发症
Arch Intern Med. 1987 Sep;147(9):1577-80.
10
The alpha interferons: clinical overview.
Semin Oncol. 1987 Jun;14(2 Suppl 2):1-12.
Zotero 插件